Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
11 February 2021Website:
http://www.bioventus.comNext earnings report:
08 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 19:45:30 GMTDividend
Analysts recommendations
Institutional Ownership
BVS Latest News
Here, we discuss some reasons why buying Bioventus (BVS) stock now may turn out to be a prudent move.
Shares of BVS are up more than 100% over the past year amid an ongoing financial turnaround. The company is benefiting from strong demand for its portfolio of minimally invasive medical treatment including therapeutic injections for osteoarthritis. Shares are attractively priced ahead of the Q4 earnings report where we expect management to deliver positive 2024 guidance.
Bioventus Inc. (NASDAQ:BVS ) Q3 2023 Earnings Conference Call November 7, 2023 8:30 AM ET Company Participants Dave Crawford - Vice President, Investor Relations Tony Bihl - Chief Executive Officer Mark Singleton - Senior Vice President and Chief Financial Officer Conference Call Participants Chase Knickerbocker - Craig-Hallum Lilia-Celine Lozada - JPMorgan Bill Plovanic - Canaccord Operator Thank you for standing by. My name is Dustin, and I will be your conference operator today.
DURHAM, N.C., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the third quarter of fiscal year 2023 before the market opens on Tuesday, November 7, 2023. The Company's management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update.
Bioventus Inc. is attempting to move forward from disappointing results in recent years including the failed acquisition of "CartiHeal." The company expects growth to reaccelerate into 2024 as recent pricing pressures stabilize. We expect Bioventus Inc. shares to remain volatile but see an upside as earnings improve going forward.
We have narrowed our search to three value stocks from the Medical sector. These are PHG, RDNT and BVS.
DURHAM, N.C., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, senior vice president and chief financial officer, will participate in a fireside chat at the Cantor Global Healthcare Conference on Thursday, September 28, 2023, at 1:50 p.m. ET.
DURHAM, N.C., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Tony Bihl, interim chief executive officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on Wednesday, September 13, 2023, at 8:50 a.m. ET.
Investing in penny stocks represents an enticing prospect for those seeking to leverage the stock market's potential gains. Characterized by an inherent risk and the promise of significant rewards, these under-$5 shares often become the subjects of speculation.
Penny stocks provide a captivating opportunity for those aiming to profit in the stock market. The intrinsic risk and potential rewards associated with these stocks often lead to intense speculation and a quest for remarkable profits.
What type of business is Bioventus?
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies include an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.
What sector is Bioventus in?
Bioventus is in the Healthcare sector
What industry is Bioventus in?
Bioventus is in the Medical Devices industry
What country is Bioventus from?
Bioventus is headquartered in United States
When did Bioventus go public?
Bioventus initial public offering (IPO) was on 11 February 2021
What is Bioventus website?
https://www.bioventus.com
Is Bioventus in the S&P 500?
No, Bioventus is not included in the S&P 500 index
Is Bioventus in the NASDAQ 100?
No, Bioventus is not included in the NASDAQ 100 index
Is Bioventus in the Dow Jones?
No, Bioventus is not included in the Dow Jones index
When does Bioventus report earnings?
The next expected earnings date for Bioventus is 08 August 2024